If you are comparing types of psilocybin mushrooms, you are looking at a large group of fungi spread across several genera, with Psilocybe containing many of the best studied species. Psilocybe cubensis, Psilocybe semilanceata, Psilocybe cyanescens, Psilocybe azurescens and Panaeolus cyanescens are among the species most often discussed in scientific and forensic literature. Their psilocybin, psilocin and minor alkaloid content can differ substantially between species, between samples of the same species and even between fruiting bodies from the same cultivated line.
How many psilocybin mushroom species exist
You will often see the figure stated as roughly 200 psilocybin-producing mushroom species. A 2022 scientific review described psilocybin as a naturally occurring alkaloid produced by approximately 200 mushroom species. A 2024 phylogenomic study described about 165 species within Psilocybe itself, while noting that taxonomy and chemistry remain incomplete across much of the genus.
That count should be treated as an estimate. Taxonomic names change as DNA data improves, older collections can be misidentified and some species have stronger chemical confirmation than others. In a DNA and chemical study of fungarium specimens, researchers found widespread identification errors and major inconsistencies in recorded metabolites. If you are reading a species list, you should give more weight to records supported by DNA authentication and direct chemical testing.
You also need to look outside Psilocybe. Psilocybin-producing fungi have been reported in genera including Panaeolus and Gymnopilus. A global review of Panaeolus identified 77 accepted species and reported hallucinogenic properties for 20 of them, while also noting that chemical evidence remains incomplete for many species.
The practical answer is that you are dealing with around 200 reported psilocybin-producing mushroom species, with different levels of taxonomic and chemical certainty. The best studied species account for a much smaller group.
Psilocybe cubensis, the most cultivated species
When you encounter psilocybin mushroom research outside a purified drug setting, Psilocybe cubensis appears frequently because it is widely cultivated and can be produced under controlled conditions. It is a dung-associated species linked strongly with cattle and other large herbivores. Scientific reports describe it from warm regions across several continents, and recent genetic work continues to refine its history and geographic origin.
You should avoid treating a cubensis strain name as a fixed chemical specification. A 2024 analytical study measured five cultivated P. cubensis strains and found average combined psilocybin and psilocin concentrations ranging from 0.879 percent to 1.36 percent by dry weight. A 2026 study of 14 P. cubensis strains grown under standardized conditions reported total measured tryptamine concentrations from 2.62 to 20.65 milligrams per gram. That is a difference of more than sevenfold even under controlled cultivation.
This variation affects how you should read claims about Golden Teacher, B+, Blue Meanie or other informal cubensis names. The name alone does not give you a reliable alkaloid concentration. Genetics, cultivation conditions, developmental stage, drying, storage and laboratory method can all affect the final measurement.
P. cubensis remains useful in research because you can cultivate it in controlled settings, sample multiple fruiting bodies and compare chemistry across strains or production conditions. For species-level reference work, that repeatability gives researchers a practical model for studying natural psilocybin-containing fungal material.
Psilocybe semilanceata, liberty cap
Psilocybe semilanceata is commonly called the liberty cap. If you compare it with P. cubensis, you are looking at a species associated more strongly with temperate grasslands. Research from Norway documented it in grassy habitats across much of the country during late summer and autumn.
Its chemistry has drawn scientific attention for decades. Norwegian samples in one study contained 0.17 to 1.96 percent psilocybin by dry weight. Finnish samples in another study contained 0.62 to 2.37 percent psilocybin by dry weight, with a mean of 1.42 percent. Low concentrations of psilocin were also detected in some Finnish samples.
Those figures show why you should avoid assigning one potency number to the species. Collection site, specimen age, storage and analytical method affect measured values. A later fungarium study also showed that alkaloid stability changes with specimen age and differs across species.
P. semilanceata also contains minor tryptamine alkaloids. Baeocystin has been detected alongside psilocybin, while psilocin can appear at much lower levels in some collections. The pharmacological contribution of these minor compounds in humans remains poorly defined.
Psilocybe cyanescens, wavy cap
Psilocybe cyanescens is widely known as the wavy cap. You will usually encounter it in scientific literature as a wood-associated Psilocybe species with documented psilocybin and psilocin content.
Chemical data for P. cyanescens reinforces the same caution seen with other species. Historical work across wild mushroom collections found large differences in total psilocybin and psilocin from one collection to another. Later DNA and metabolite work on P. cyanescens, P. cubensis and P. semilanceata also found that specimen identity and storage history can strongly affect chemical results.
You may also see baeocystin reported in P. cyanescens. Early analytical work detected baeocystin across several Psilocybe, Conocybe and Panaeolus collections, including cultivated P. cyanescens. This is one reason researchers increasingly discuss a broader tryptamine profile instead of reporting psilocybin alone.
For you as a reader, the key point is that wavy cap chemistry is real and measurable, while a single universal potency value would overstate what the evidence can support.
Psilocybe azurescens
Psilocybe azurescens is regularly cited among high-alkaloid Psilocybe species. It is associated with the Pacific Northwest of North America and with lignin-rich plant debris and woody substrates.
Recent controlled research has helped put species comparisons on firmer analytical footing. A 2025 reference-material study successfully cultivated P. azurescens along with five other Psilocybe species under controlled indoor conditions. Researchers confirmed species identity through anatomy, microscopy and DNA sequencing, then measured psilocybin and psilocin and identified minor compounds including norbaeocystin, baeocystin and aeruginascin. The study found clear species-level differences and also reported effects from storage conditions, mushroom developmental stage and cap-versus-stem sampling.
When you read claims that P. azurescens is the strongest psilocybin mushroom, treat the statement as shorthand rather than a fixed scientific ranking. Published measurements place it among high-potency species, yet cross-study ranking changes with the sample, chemical target and laboratory method. A scientifically useful comparison names the compounds measured, the dry-weight basis, the sample conditions and the analytical method.
Panaeolus cyanescens, blue meanie
Panaeolus cyanescens belongs to a different genus from Psilocybe. You may also see older literature use the name Copelandia cyanescens. The common name blue meanie can create confusion because the same phrase has also been used informally for a P. cubensis cultivar.
Panaeolus species occur in several ecological settings, with many linked to dung, pasture or grassland habitats. A global review found 77 accepted Panaeolus species and reported hallucinogenic properties for 20, while calling attention to major gaps in DNA and chemical verification across the genus.
P. cyanescens has produced high psilocin measurements in forensic studies. One analytical report found dried P. cyanescens samples with psilocin concentrations reaching about 3 milligrams per 100 milligrams of dried material. Another forensic study comparing commonly encountered psychoactive fungi reported P. cyanescens as the sample with the highest combined psilocybin and psilocin levels in that collection.
You should read those findings as measurements from specific samples. They do not set a universal concentration for every P. cyanescens specimen.
How potency compares across species
If you want a useful species comparison, look at measured alkaloids instead of common names or reputation. Psilocybin and psilocin are the main compounds usually quantified, while baeocystin, norbaeocystin, aeruginascin and norpsilocin may also appear in chemical profiles.
| Species | What published data shows | Main caution |
|---|---|---|
| Psilocybe cubensis | Cultivated samples have shown substantial variation across strains and individual mushrooms | Informal strain name does not fix potency |
| Psilocybe semilanceata | Studies have reported psilocybin from well below 1 percent to above 2 percent dry weight | Geography and sample condition affect results |
| Psilocybe cyanescens | Psilocybin, psilocin and baeocystin are documented | Stored specimens can lose or shift measurable alkaloids |
| Psilocybe azurescens | Frequently falls among high-alkaloid Psilocybe species in analytical work | A stable universal rank is not supported |
| Panaeolus cyanescens | Some studies have measured very high psilocin levels | It belongs to another genus and sample variation remains large |
A classic analysis of 20 wild mushroom species found that psilocybin and psilocin concentrations varied by more than sevenfold between collections. Total levels in species known to contain these alkaloids ranged from about 0.1 percent to nearly 2 percent dry weight in that study. Newer work using modern chromatography and DNA confirmation continues to show the same broad pattern of chemical variability.
What changes a potency measurement
When you compare a laboratory result, you should check several variables.
- Species identity
- Genetic line or isolate
- Fruiting body sampled
- Cap and stem proportions
- Developmental stage
- Cultivation conditions
- Drying method
- Storage temperature and duration
- Extraction method
- Analytical method
- Which alkaloids were included in the total
These variables explain why two studies can report different numbers for the same species without either study being inherently wrong. They may be measuring different biological material under different conditions.
Do different species produce different effects
You cannot reliably assign a distinct human psychological effect profile to each mushroom species from current clinical evidence. Species can differ in their ratios of psilocybin, psilocin and minor tryptamines, but controlled human trials rarely compare whole mushroom species head to head.
For you, the most defensible reading is that total active exposure, individual physiology and the conditions surrounding use have stronger human evidence than species labels as predictors of acute experience. Minor alkaloids remain an active area of chemical and pharmacological research.
Amanita muscaria and other mushrooms outside the psilocybin group
Amanita muscaria, the fly agaric, is psychoactive but belongs in a separate chemical category. If you are classifying mushrooms by their main psychoactive compounds, you should not place A. muscaria in a psilocybin species list.
Its principal psychoactive compounds are ibotenic acid and muscimol. Laboratory studies have repeatedly measured these compounds in A. muscaria and related Amanita species. Muscimol acts mainly through GABA-related signaling, while psilocin acts primarily at serotonin receptors including 5-HT2A. These are different pharmacological systems with different toxicological profiles.
This distinction has direct safety value. A red cap or cultural association with hallucinogenic mushrooms tells you very little about chemistry. Scientific classification, verified identity and chemical analysis provide a firmer basis for discussing psychoactive fungi.
Conclusion
When you read modern human clinical research, you will most often see a measured dose of purified psilocybin rather than a named mushroom species. This allows investigators to control the administered amount and reduce variability between participants. Recent randomized trials commonly report a defined psilocybin dose rather than administration of whole mushroom material.
Whole mushroom species still play a major role in mycology, analytical chemistry, genetics and reference-material research. P. cubensis receives frequent attention because it can be cultivated under controlled conditions and sampled repeatedly. Recent research has also cultivated and chemically profiled species including P. azurescens, P. cyanescens, P. zapotecorum, P. natalensis, P. subaeruginosa and P. stuntzii to build better species reference data.
If your interest is therapeutic research, you should keep these two research tracks separate in your reading. Human treatment studies tell you about measured psilocybin in controlled clinical settings. Fungal studies tell you how natural species produce, vary and retain psilocybin, psilocin and related compounds.
That distinction also helps explain the positive medical interest in psychedelics. A randomized trial led by researchers at Johns Hopkins University found that psilocybin-assisted therapy produced substantial reductions in depressive symptoms in adults with major depressive disorder under controlled conditions. Later randomized studies have continued to report antidepressant effects while also stressing the need for careful screening, clinical support and further research.
As you read species-level data, we at Rose Hill Life Sciences focus on the production and research of Psilocybe cubensis as a psychedelic research organization working at the intersection of science and therapeutic integration. Our work also includes Massachusetts based research connected to the scientific study of psilocybin-producing fungi and related research questions.
For you, the most useful way to compare psilocybin mushroom species is to start with verified taxonomy, measured chemistry and the conditions under which each sample was tested. Species names give you a biological category. Laboratory data tells you what compounds were actually present in that sample and at what concentration.
Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.
